EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study

Dana Bliuc iD, Thach Tran iD, Weiwen Chen iD, Dunia Alarkawi iD, Dima A Alajlouni iD, Fiona Blyth, Lyn March, Kristine E Ensrud, Robert D Blank iD, Jacqueline R Center iD

PLOS Medicine · 17.01.2023 · 20 (1) · e1004142

DOI: 10.1371/journal.pmed.1004142 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PLOS Medicine, online erschienen am 17.01.2023. Verfasst von Dana Bliuc und 9 weiteren Autor:innen. Beteiligte Einrichtung: Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Osteoporosis, Osteoporotic Fractures. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen Foundation, National Health and Medical Research Council, Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multimorbidity is common among fracture patients. However, its association with osteoporosis investigation and treatment to prevent future fractures is unclear. This limited knowledge impedes optimal patient care. This study investigated the association between multimorbidity and osteoporosis investigation and treatment in persons at high risk following an osteoporotic fracture. Methods and findings The Sax Institute’s 45 and Up Study is a prospective population-based cohort of 267,153 people in New South Wales, Australia, recruited between 2005 and 2009. This analysis followed up participants until 2017 for a median of 6 years (IQR: 4 to 8). Questionnaire data were linked to hospital admissions (Admitted Patients Data Collection (APDC)), emergency presentations (Emergency Department Data Collection (EDDC)), Pharmaceutical Benefits Scheme (PBS), and Medicare Benefits Schedule (MBS). Data were linked by the Centre for Health Record Linkage and stored in a secured computing environment. Fractures were identified from APDC and EDDC, Charlson Comorbidity Index (CCI) from APDC, Dual-energy X-ray absorptiometry (DXA) investigation from MBS, and osteoporosis treatment from PBS. Out of 25,280 persons with index fracture, 10,540 were classified as high-risk based on 10-year Garvan Fracture Risk (age, sex, weight, prior fracture and falls) threshold ≥20%. The association of CCI with likelihood of investigation and treatment initiation was determined by logistic regression adjusted for education, socioeconomic and lifestyle factors). The high-risk females and males averaged 77 ± 10 and 86 ± 5 years, respectively; >40% had a CCI ≥2. Only 17% of females and 7% of males received a DXA referral, and 22% of females and 14% males received osteoporosis medication following fracture. A higher CCI was associated with a lower probability of being investigated [adjusted OR, females: 0.73 (95% CI, 0.61 to 0.87) and 0.43 (95% CI, 0.30 to 0.62); males: 0.47 (95% CI, 0.33 to 0.68) and 0.52 (0.31 to 0.85) for CCI: 2 to 3, and ≥4 versus 0 to 1, respectively] and of receiving osteoporosis medication [adjusted OR, females: 0.85 (95% CI, 0.74 to 0.98) and 0.78 (95% CI, 0.61 to 0.99); males: 0.75 (95% CI, 0.59 to 0.94) and 0.37 (95% CI, 0.23 to 0.53) for CCI: 2 to 3, and ≥4 versus 0 to 1, respectively]. The cohort is relatively healthy; therefore, the impact of multimorbidity on osteoporosis management may have been underestimated.

Conclusions

Multimorbidity contributed significantly to osteoporosis treatment gap. This suggests that fracture risk is either underestimated or underprioritized in the context of multimorbidity and highlights the need for extra vigilance and improved fracture care in this setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisOsteoporotic FracturesMaleFemaleHumansAgedProspective StudiesMultimorbidityNational Health ProgramsAustraliaAbsorptiometry, Photon

Autor:innen und Institutionen

  • Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  • School of Population Health, Faculty of Medicine and Health, UNSW, Sydney, New South Wales, Australia.
  • St Vincent's Clinical School, Faculty of Medicine and Health, UNSW, New South Wales, Australia.
  • Concord Clinical School, University of Sydney, Sydney, Australia.
  • Institute of Bone & Joint Research, University of Sydney, Sydney, Australia.
  • Center for Care Delivery and Outcomes Research, Minneapolis VA Healthcare System, Minneapolis, Minnesota, United States of America.

ORCID-Profile: Dana Bliuc, Thach Tran, Weiwen Chen, Dunia Alarkawi, Dima A Alajlouni, Robert D Blank, Jacqueline R Center

Förderung

  • Amgen Foundation
  • National Health and Medical Research Council
  • Medical Research Future Fund
  • Mrs Gibson and Ernst Heine Family Foundation

Zitieren

APA

Bliuc, D., Tran, T., Chen, W., Alarkawi, D., Alajlouni, D. A., Blyth, F., March, L., Ensrud, K. E., Blank, R. D., & Center, J. R. (2023). The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study. PLOS Medicine, 20(1), e1004142. https://doi.org/10.1371/journal.pmed.1004142

Vancouver

Bliuc D, Tran T, Chen W, Alarkawi D, Alajlouni DA, Blyth F, et al. The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study. PLOS Medicine. 2023;20(1):e1004142. doi:10.1371/journal.pmed.1004142

BibTeX
@article{Bliuc2023,
  author = {Bliuc, Dana and Tran, Thach and Chen, Weiwen and Alarkawi, Dunia and Alajlouni, Dima A and Blyth, Fiona and March, Lyn and Ensrud, Kristine E and Blank, Robert D and Center, Jacqueline R},
  title = {The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study},
  journal = {PLOS Medicine},
  year = {2023},
  volume = {20},
  number = {1},
  pages = {e1004142},
  doi = {10.1371/journal.pmed.1004142}
}
Kostenlos starten →